Momenta Pharmaceuticals, Inc. (MNTA)

[flatlander_60048]

Given that it appears that Ampha infringed the 466 patent, at least to gain ANDA approval, what is the potential that the judge uses the next week of TRO extension to strongly prod the parties toward settlement. Seems like the threat of a PI and the possibility of future civil damages lawsuits should get the parties to find some kind of compromise.

Is more discovery potentially in order (i.e., what QA/QC procedures will Ampha use during production that will not infringe?

FL